R&D JP Morgan Week 2025 – Ryan Spencer Join CEO Ryan Spencer of Dynavax Technologies in a video interview discussing JP Morgan Week 2025
R&D JP Morgan Week 2025 – Paul Hastings At JP Morgan last month, pharmaphorum caught up with Paul Hastings, the CEO of Nkarta, to talk about NK cells and autoimmune diseases.
Digital JP Morgan Week 2025 – Phil Johnson Phil Johnson chat about why he joined Evidation and his excitement about the company’s mission.
Patients JP Morgan Week 2025 – Rick Stewart At JPM Week 2025 in San Francisco, pharmaphorum editor-in-chief Jonah Comstock met with Rick Stewart, CEO of Achieve Life Sciences.
R&D JP Morgan Week 2025 – Steve Pakola On the sidelines of JP Morgan in San Francisco, editor-in-chief Jonah Comstock caught up with Steven Pakola, REGENXBIO’s chief medical officer.
Oncology JP Morgan Week 2025 – Marianne De Backer At JPM 2025, pharmaphorum editor-in-chief Jonah Comstock spoke with Vir Biotechnology CEO Marianne De Backer.
News FDA finally okays Novavax's COVID-19 jab, with restrictions The FDA has granted full approval to Novavax's COVID-19 vaccine after a delay, but has limited its use.
Market Access Sponsored Bridging research and clinical guidelines – interactive stra... Medical affairs is evolving. Understanding how to harness real-world data and digital insights is essential.